Global Melphalan Hydrochloride API Market Research Report 2023

Publication ID:

PB504232729

Publication Date:

April 21, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Melphalan Hydrochloride API market was valued at US$ 270 million in 2022 and is anticipated to reach US$ 405.7 million by 2029, witnessing a CAGR of 6.0% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Melphalan Hydrochloride API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Melphalan Hydrochloride API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Melphalan Hydrochloride API include AUROBINDO PHARMA LTD, GRANULES INDIA LTD, NAVINTA LLC, HETERO LABS LTD, SHILPA MEDICARE LTD, BIOPHORE INDIA PHARMACEUTICALS PVT LTD, NERPHARMA SRL, FARMABIOS SPA and EMCURE PHARMACEUTICALS LTD, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Melphalan Hydrochloride API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melphalan Hydrochloride API.
The Melphalan Hydrochloride API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Melphalan Hydrochloride API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Melphalan Hydrochloride API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
AUROBINDO PHARMA LTD
GRANULES INDIA LTD
NAVINTA LLC
HETERO LABS LTD
SHILPA MEDICARE LTD
BIOPHORE INDIA PHARMACEUTICALS PVT LTD
NERPHARMA SRL
FARMABIOS SPA
EMCURE PHARMACEUTICALS LTD
OLON SPA
Segment by Type
笔耻谤颈迟测鈮�98%
Purity<98%
Segment by Application
Injection
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Melphalan Hydrochloride API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Melphalan Hydrochloride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Melphalan Hydrochloride API Market Overview
1.1 Product Overview and Scope of Melphalan Hydrochloride API
1.2 Melphalan Hydrochloride API Segment by Type
1.2.1 Global Melphalan Hydrochloride API Market Value Comparison by Type (2023-2029)
1.2.2 笔耻谤颈迟测鈮�98%
1.2.3 Purity<98%
1.3 Melphalan Hydrochloride API Segment by Application
1.3.1 Global Melphalan Hydrochloride API Market Value by Application: (2023-2029)
1.3.2 Injection
1.3.3 Others
1.4 Global Melphalan Hydrochloride API Market Size Estimates and Forecasts
1.4.1 Global Melphalan Hydrochloride API Revenue 2018-2029
1.4.2 Global Melphalan Hydrochloride API Sales 2018-2029
1.4.3 Global Melphalan Hydrochloride API Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Melphalan Hydrochloride API Market Competition by Manufacturers
2.1 Global Melphalan Hydrochloride API Sales Market Share by Manufacturers (2018-2023)
2.2 Global Melphalan Hydrochloride API Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Melphalan Hydrochloride API Average Price by Manufacturers (2018-2023)
2.4 Global Melphalan Hydrochloride API Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Melphalan Hydrochloride API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Melphalan Hydrochloride API, Product Type & Application
2.7 Melphalan Hydrochloride API Market Competitive Situation and Trends
2.7.1 Melphalan Hydrochloride API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Melphalan Hydrochloride API Players Market Share by Revenue
2.7.3 Global Melphalan Hydrochloride API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Melphalan Hydrochloride API Retrospective Market Scenario by Region
3.1 Global Melphalan Hydrochloride API Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Melphalan Hydrochloride API Global Melphalan Hydrochloride API Sales by Region: 2018-2029
3.2.1 Global Melphalan Hydrochloride API Sales by Region: 2018-2023
3.2.2 Global Melphalan Hydrochloride API Sales by Region: 2024-2029
3.3 Global Melphalan Hydrochloride API Global Melphalan Hydrochloride API Revenue by Region: 2018-2029
3.3.1 Global Melphalan Hydrochloride API Revenue by Region: 2018-2023
3.3.2 Global Melphalan Hydrochloride API Revenue by Region: 2024-2029
3.4 North America Melphalan Hydrochloride API Market Facts & Figures by Country
3.4.1 North America Melphalan Hydrochloride API Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Melphalan Hydrochloride API Sales by Country (2018-2029)
3.4.3 North America Melphalan Hydrochloride API Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Melphalan Hydrochloride API Market Facts & Figures by Country
3.5.1 Europe Melphalan Hydrochloride API Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Melphalan Hydrochloride API Sales by Country (2018-2029)
3.5.3 Europe Melphalan Hydrochloride API Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Melphalan Hydrochloride API Market Facts & Figures by Country
3.6.1 Asia Pacific Melphalan Hydrochloride API Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Melphalan Hydrochloride API Sales by Country (2018-2029)
3.6.3 Asia Pacific Melphalan Hydrochloride API Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Melphalan Hydrochloride API Market Facts & Figures by Country
3.7.1 Latin America Melphalan Hydrochloride API Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Melphalan Hydrochloride API Sales by Country (2018-2029)
3.7.3 Latin America Melphalan Hydrochloride API Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Melphalan Hydrochloride API Market Facts & Figures by Country
3.8.1 Middle East and Africa Melphalan Hydrochloride API Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Melphalan Hydrochloride API Sales by Country (2018-2029)
3.8.3 Middle East and Africa Melphalan Hydrochloride API Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Melphalan Hydrochloride API Sales by Type (2018-2029)
4.1.1 Global Melphalan Hydrochloride API Sales by Type (2018-2023)
4.1.2 Global Melphalan Hydrochloride API Sales by Type (2024-2029)
4.1.3 Global Melphalan Hydrochloride API Sales Market Share by Type (2018-2029)
4.2 Global Melphalan Hydrochloride API Revenue by Type (2018-2029)
4.2.1 Global Melphalan Hydrochloride API Revenue by Type (2018-2023)
4.2.2 Global Melphalan Hydrochloride API Revenue by Type (2024-2029)
4.2.3 Global Melphalan Hydrochloride API Revenue Market Share by Type (2018-2029)
4.3 Global Melphalan Hydrochloride API Price by Type (2018-2029)
5 Segment by Application
5.1 Global Melphalan Hydrochloride API Sales by Application (2018-2029)
5.1.1 Global Melphalan Hydrochloride API Sales by Application (2018-2023)
5.1.2 Global Melphalan Hydrochloride API Sales by Application (2024-2029)
5.1.3 Global Melphalan Hydrochloride API Sales Market Share by Application (2018-2029)
5.2 Global Melphalan Hydrochloride API Revenue by Application (2018-2029)
5.2.1 Global Melphalan Hydrochloride API Revenue by Application (2018-2023)
5.2.2 Global Melphalan Hydrochloride API Revenue by Application (2024-2029)
5.2.3 Global Melphalan Hydrochloride API Revenue Market Share by Application (2018-2029)
5.3 Global Melphalan Hydrochloride API Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AUROBINDO PHARMA LTD
6.1.1 AUROBINDO PHARMA LTD Corporation Information
6.1.2 AUROBINDO PHARMA LTD Description and Business Overview
6.1.3 AUROBINDO PHARMA LTD Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AUROBINDO PHARMA LTD Melphalan Hydrochloride API Product Portfolio
6.1.5 AUROBINDO PHARMA LTD Recent Developments/Updates
6.2 GRANULES INDIA LTD
6.2.1 GRANULES INDIA LTD Corporation Information
6.2.2 GRANULES INDIA LTD Description and Business Overview
6.2.3 GRANULES INDIA LTD Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GRANULES INDIA LTD Melphalan Hydrochloride API Product Portfolio
6.2.5 GRANULES INDIA LTD Recent Developments/Updates
6.3 NAVINTA LLC
6.3.1 NAVINTA LLC Corporation Information
6.3.2 NAVINTA LLC Description and Business Overview
6.3.3 NAVINTA LLC Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2018-2023)
6.3.4 NAVINTA LLC Melphalan Hydrochloride API Product Portfolio
6.3.5 NAVINTA LLC Recent Developments/Updates
6.4 HETERO LABS LTD
6.4.1 HETERO LABS LTD Corporation Information
6.4.2 HETERO LABS LTD Description and Business Overview
6.4.3 HETERO LABS LTD Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 HETERO LABS LTD Melphalan Hydrochloride API Product Portfolio
6.4.5 HETERO LABS LTD Recent Developments/Updates
6.5 SHILPA MEDICARE LTD
6.5.1 SHILPA MEDICARE LTD Corporation Information
6.5.2 SHILPA MEDICARE LTD Description and Business Overview
6.5.3 SHILPA MEDICARE LTD Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2018-2023)
6.5.4 SHILPA MEDICARE LTD Melphalan Hydrochloride API Product Portfolio
6.5.5 SHILPA MEDICARE LTD Recent Developments/Updates
6.6 BIOPHORE INDIA PHARMACEUTICALS PVT LTD
6.6.1 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Corporation Information
6.6.2 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Description and Business Overview
6.6.3 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2018-2023)
6.6.4 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Melphalan Hydrochloride API Product Portfolio
6.6.5 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Recent Developments/Updates
6.7 NERPHARMA SRL
6.6.1 NERPHARMA SRL Corporation Information
6.6.2 NERPHARMA SRL Description and Business Overview
6.6.3 NERPHARMA SRL Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 NERPHARMA SRL Melphalan Hydrochloride API Product Portfolio
6.7.5 NERPHARMA SRL Recent Developments/Updates
6.8 FARMABIOS SPA
6.8.1 FARMABIOS SPA Corporation Information
6.8.2 FARMABIOS SPA Description and Business Overview
6.8.3 FARMABIOS SPA Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2018-2023)
6.8.4 FARMABIOS SPA Melphalan Hydrochloride API Product Portfolio
6.8.5 FARMABIOS SPA Recent Developments/Updates
6.9 EMCURE PHARMACEUTICALS LTD
6.9.1 EMCURE PHARMACEUTICALS LTD Corporation Information
6.9.2 EMCURE PHARMACEUTICALS LTD Description and Business Overview
6.9.3 EMCURE PHARMACEUTICALS LTD Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2018-2023)
6.9.4 EMCURE PHARMACEUTICALS LTD Melphalan Hydrochloride API Product Portfolio
6.9.5 EMCURE PHARMACEUTICALS LTD Recent Developments/Updates
6.10 OLON SPA
6.10.1 OLON SPA Corporation Information
6.10.2 OLON SPA Description and Business Overview
6.10.3 OLON SPA Melphalan Hydrochloride API Sales, Revenue and Gross Margin (2018-2023)
6.10.4 OLON SPA Melphalan Hydrochloride API Product Portfolio
6.10.5 OLON SPA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Melphalan Hydrochloride API Industry Chain Analysis
7.2 Melphalan Hydrochloride API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Melphalan Hydrochloride API Production Mode & Process
7.4 Melphalan Hydrochloride API Sales and Marketing
7.4.1 Melphalan Hydrochloride API Sales Channels
7.4.2 Melphalan Hydrochloride API Distributors
7.5 Melphalan Hydrochloride API Customers
8 Melphalan Hydrochloride API Market Dynamics
8.1 Melphalan Hydrochloride API Industry Trends
8.2 Melphalan Hydrochloride API Market Drivers
8.3 Melphalan Hydrochloride API Market Challenges
8.4 Melphalan Hydrochloride API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

AUROBINDO PHARMA LTD
GRANULES INDIA LTD
NAVINTA LLC
HETERO LABS LTD
SHILPA MEDICARE LTD
BIOPHORE INDIA PHARMACEUTICALS PVT LTD
NERPHARMA SRL
FARMABIOS SPA
EMCURE PHARMACEUTICALS LTD
OLON SPA

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂